Related references
Note: Only part of the references are listed.Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression A Randomized Clinical Trial
Sabine Aust et al.
JAMA PSYCHIATRY (2022)
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial
Rebecca B. Price et al.
AMERICAN JOURNAL OF PSYCHIATRY (2022)
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F. Ionescu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
Samuel T. Wilkinson et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2021)
Syndromic Surveillance of Suicidal Ideation and Self-Directed Violence — United States, January 2017–December 2018
Marissa L. Zwald et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Double-Blind, Randomized Study (ASPIRE I)
Dong-Jing Fu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
Ewa Wajs et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression
Samuel T. Wilkinson et al.
BIOLOGICAL PSYCHIATRY (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT
Michael E. Thase et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression
Samuel T. Wilkinson et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
Suicide Rates After Discharge From Psychiatric Facilities A Systematic Review and Meta-analysis
Daniel Thomas Chung et al.
JAMA PSYCHIATRY (2017)
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial
Michael F. Grunebaum et al.
BIPOLAR DISORDERS (2017)
Beyond the Label: Relationship Between Community Therapists' Self-Report of a Cognitive Behavioral Therapy Orientation and Observed Skills
Torrey A. Creed et al.
ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH (2016)
Brief Cognitive-Behavioral Therapy Effects on Post-Treatment Suicide Attempts in a Military Sample: Results of a Randomized Clinical Trial With 2-Year Follow-Up
M. David Rudd et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches
Rayan K. Al Jurdi et al.
CURRENT PSYCHIATRY REPORTS (2015)
Existing and Novel Biological Therapeutics in Suicide Prevention
Joshua J. Griffiths et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2014)
Cognitive-Behavioral Therapy as Continuation Treatment to Sustain Response After Electroconvulsive Therapy in Depression: A Randomized Controlled Trial
Eva-Lotta Brakemeier et al.
BIOLOGICAL PSYCHIATRY (2014)
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
Paulo R. Shiroma et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
A road map for suicide research and prevention
Andre Aleman et al.
NATURE (2014)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Suicidal Thoughts and Behavior With Antidepressant Treatment Reanalysis of the Randomized Placebo-Controlled Studies of Fluoxetine and Venlafaxine
Robert D. Gibbons et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Meta-Analysis of Efficacy and Treatment-Emergent Suicidality in Adults by Psychiatric Indication and Age Subgroup Following Initiation of Paroxetine Therapy: A Complete Set of Randomized Placebo-Controlled Trials
David J. Carpenter et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes
Roy H. Perlis et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Cognitive therapy for the prevention of suicide attempts - A randomized controlled trial
GK Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Computer-assisted cognitive therapy for depression: Maintaining efficacy while reducing therapist time
JH Wright et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression
SD Hollon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Antidepressants and the risk of suicidal behaviors
H Jick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Psychological autopsy studies of suicide: a systematic review
JTO Cavanagh et al.
PSYCHOLOGICAL MEDICINE (2003)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
